Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Short-term Debt
Borrowings and the current portion of long-term debt due within one year.
Microbot Medical Inc.NASDAQ: MBOT
Short-term Debt · Q1 FY2026 · quarter ended Mar 2026
Short-term debt remains negative
Q1 FY2026 short-term debt was $324K, compared with $0 a year earlier.
Context
- Short-term debt amounted to 0.4% of total assets at the end of Q1 FY2026, up 0.4 pp from a year earlier.
- Short-term debt increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Short-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 283K | — |
| FY2021 | 2021-12-31 | 0 | — |
Short-term Debt vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so short-term debt is compared through growth and share of total assets rather than absolute size.
- Short-term debt amounts to 0.4% of total assets for MBOT, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $46.14M USD | — | — | 89.5% | |
| Mar 2026 | $1.87M USD | -40.2% | -14.1% | 8.6% | |
| Mar 2026 | $1.46M USD | — | — | 0.6% | |
| Mar 2026 | $324K USD | — | — | 0.4% | |
| Mar 2026 | $268K USD | — | — | 0.1% | |
| Mar 2026 | CA$162.15K CAD | -53.2% | -45.4% | 1.1% | |
| Mar 2026 | $49.28K USD | -99.8% | -57.3% | 0.0% | |
| Mar 2026 | CA$39.89K CAD | — | — | 0.1% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding MBOT) | — | -53.2% | -45.4% | 0.1% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.